Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.
about
Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitusAdvances in diabetes for the millennium: drug therapy of type 2 diabetesNatural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a reviewInduction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcomaPPARγ agonists regulate the expression of stemness and differentiation genes in brain tumour stem cellsPPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells.Efficacy of pioglitazone on glycemic control and carotid intima-media thickness in type 2 diabetes patients with inadequate insulin therapyThiazolidinediones: a new class of antidiabetic drugs.Treating obese patients with poorly controlled diabetes: confessions of an insulin therapist.Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetesImplications of the United Kingdom prospective diabetes study for patients with obesity and type 2 diabetes.The glitazones: proceed with caution.Pharmacotherapy of type 2 diabetes mellitus.Insulin sensitiser drugs.Using dose-response characteristics of therapeutics agents for treatment decisions in type 2 diabetes.Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review.New insights into insulin resistance pathophysiology: how it affects glucose and lipid metabolism.Pharmacological treatment of the pathogenetic defects in type 2 diabetes: the randomized multicenter South Danish Diabetes StudyDifferentiating members of the thiazolidinedione class: a focus on efficacy.Genetically defined pancreatic beta cell failure.Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro.A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Co-Administration of Sitagliptin with Intensively Titrated Insulin Glargine.Serum concentrations of phthalate metabolites are related to abdominal fat distribution two years later in elderly women.Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.Emerging drugs for diabetic nephropathy.Control of peroxisome proliferator-activated receptor fate by the ubiquitinproteasome system.Troglitazone improves recovery of left ventricular function after regional ischemia in pigsComparative risk of severe hypoglycemia among concomitant users of thiazolidinedione antidiabetic agents and antihyperlipidemicsDesign, synthesis, biological activity and molecular dynamics studies of specific protein tyrosine phosphatase 1B inhibitors over SHP-2PPARalpha Ligands as Antitumorigenic and Antiangiogenic AgentsAn observational study of the effect of two thiazolidinediones on blood lipid levels: Rosiglitazone and pioglitazone in routine clinical practiceThe safety of thiazolidinediones.Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.New molecular insights in diabetic nephropathy.PPARγ signaling and emerging opportunities for improved therapeutics.Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control.On the repeated measures designs and sample sizes for randomized controlled trials.Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells.Nerium oleander Distillate Improves Fat and Glucose Metabolism in High-Fat Diet-Fed Streptozotocin-Induced Diabetic Rats.Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.
P2860
Q24246084-B519B1DA-F9A1-4CBD-941E-49330EC3AE67Q24547558-6A341B8C-5374-4511-8DFC-DB8E5DD27E80Q24561401-8DC9ABC4-1442-4E19-B912-B7B794716DC5Q28343226-846BFEF7-8995-4200-9195-78E84291CC5FQ30454765-83CB74C1-FA88-4B01-B83C-3900B579B905Q30484694-D806A78F-DA6D-4A25-AE95-DD1818BFF667Q33558402-3A2D65CE-CE5E-417F-8FE3-E4083AE0E046Q33607634-A7CC8EBE-81BE-4627-A941-61066EED0DF2Q33707387-762E7E89-F16F-40D0-9B6B-E43D2E0B5877Q33797616-541CFFEE-D009-4691-9C45-5CDCFF96B16EQ33886630-6FE787A7-DDBC-4D0B-85C5-4498285E9339Q33973778-63B3AEE1-FAD6-45AB-9562-630B2D4DBCE3Q33992531-AFF54511-E419-49C7-8098-C1B661EF7656Q34074912-C8FB0052-69DB-489E-972E-71F2CB705CB7Q34163377-7A6CBE32-9E0F-4486-A13C-08F96BFF9BCEQ34168385-F398EC3E-BA7A-4710-B5F1-7B0BE5FF254AQ34325597-684151C6-C5AF-4125-B0F3-F78BDBE5B515Q34422081-CCCAF42A-80C7-434B-BFEB-AF12C866DCBAQ34580989-C58E4E21-9307-4D14-BB17-89DED39BCE4DQ34837085-DD6D521F-55CB-4438-87BB-6DF2344D3B84Q35753181-E8D453F2-CCDE-4155-BBD3-57C098B74E4FQ35772593-62343D0B-A1CD-477E-82C2-C0A3F506093FQ36048684-88E333EF-0DA0-4209-899D-0B3B1B15E825Q36283803-744AE47A-85B6-4762-87D9-B85F3B6FA196Q36302838-94A3F40F-35B9-4CE7-935D-559641EF87B5Q36659845-B3915ADA-A975-4AC8-B2B3-5EEBC416F70FQ36787473-8450C714-91D2-464B-B1AB-A4E86762EFDDQ36959603-3163C547-2075-4EE8-8259-C1327BF9A017Q37007402-3D73CA9F-309A-4C30-A7C0-A3A3C65629FFQ37251719-48B59A53-6AEF-4BE6-A94E-C9B4F75246D2Q37719114-7694302C-7856-4687-B53E-B48ED589B27BQ37848841-4E843C0F-7F94-43A7-AC68-D7FE33EBC728Q38325827-AA58B96E-AA9D-4414-B871-A1C6E20CFB0DQ38694219-7BC1AAEF-3268-449D-BF29-3D5448A4E2DCQ38856983-A277CBA1-4E88-42FA-A0A3-F1A986589F07Q38957754-F43D1F8E-2CA4-405B-AA38-E1721F70259DQ40299208-CE8340CD-D34E-4431-83BA-12D6784CEF6EQ40923713-33347DBA-B87C-4D6F-8B37-A118F00E0829Q41927293-9DDA97C3-C354-4DF4-B9DB-BEFD251879C2Q42464570-41EE3F17-5C29-4C3F-9FEE-6D0104445D07
P2860
Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Effect of troglitazone in insu ...... Exogenous Insulin Study Group.
@en
Effect of troglitazone in insu ...... Exogenous Insulin Study Group.
@nl
type
label
Effect of troglitazone in insu ...... Exogenous Insulin Study Group.
@en
Effect of troglitazone in insu ...... Exogenous Insulin Study Group.
@nl
prefLabel
Effect of troglitazone in insu ...... Exogenous Insulin Study Group.
@en
Effect of troglitazone in insu ...... Exogenous Insulin Study Group.
@nl
P2093
P921
P1476
Effect of troglitazone in insu ...... Exogenous Insulin Study Group.
@en
P2093
Graveline JF
Schwartz S
P304
P356
10.1056/NEJM199803263381302
P407
P577
1998-03-01T00:00:00Z